Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: Randomized clinical trial

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 17, 2013, Pages 1705-1709

  Abdel Aleem, H ^a   Alhusaini, T K ^a   Abdel Aleem, M A ^a   Menoufy, M ^a   Gulmezoglu A M ^b  

^a Women Health Hospital   (Egypt)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antifibrinolytics; Blood loss; Cesarean section; Randomized clinical trial; Tranexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID;

ADULT; ARTICLE; BLEEDING; CESAREAN SECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EGYPT; ELECTIVE SURGERY; FEMALE; HEADACHE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; LENGTH OF STAY; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; VITAL SIGN;

ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; CESAREAN SECTION; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PREGNANCY; SURGICAL PROCEDURES, ELECTIVE; TRANEXAMIC ACID; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886619156     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.794210     Document Type: Article

References (13)

1. Betrán AP, Merialdi M, Lauer JA, et al. Rates of caesarean section: Analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 2007;21:98-113.
2. Queenan JT. How to stop the relentless rise in cesarean deliveries. Obstet Gynecol 2011;118:199-200.
3. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007.
4. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010; 376:23-32.
5. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2010. Art. No.: CD007872. DOI: 10.1002/14651858.CD007872.pub2.
6. WHO recommendations for the prevention and treatment of postpartum haemorrhage. 1. Postpartum hemorrhage-prevention and control. 2. Postpartum hemorrhage-Therapy. 3. Obstetric labor complications. 4. Guideline. I. World Health Organization. ISBN 97892 41548502 (NLM classification: WQ330) WHO 2012.
7. Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: A multicenter, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004;112:154-7.
8. Gohel M, Patel P, Ashoo G, Desai P. Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: A randomized case controlled prospective study. J Obstet Gynecol India 2007;57:227-30.
9. Gungorduk K, Ascoǧlu O, Gungorduk OC, et al. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: A prospective, randomized, doubleblind, placebo-controlled study. Am J Perinatol 2011;28:233-40.
10. Sekhavat L, Tabatabaii A, Dalili M, et al. Efficacy of tranexamic acid in reducing blood loss after cesarean section. Matern Fetal Neonatal Med 2009;22:72-5.
11. Gobbur VR, Reddy SV, Bijapur UJ. Efficacy of tranexamic acid in reducing blood loss during lower segment caesarean section. In: 54th All India Congress of Obstetrics and Gynaecology; 2011 Jan 5-9; Hyderabad, Andhra Pradesh, India.
12. Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. Int J Gynaecol Obstet 2011;15:224-6.
13. Beazley JM. Caesarian section. In: Turnbull A, Chamberlain G, eds. Obstetrics. Edinburgh: Churchill Livingstone; 1989:857-65.